Table 3 Candidate lipid markers for hepatic fibrosis induced by CCL4 and LS
Class | Ion | Fatty side chains | CCL4 | LS |
|---|---|---|---|---|
LPC | LPC(18:0) | 18:0 | − | ↑ |
LPC | LPC(18:3) | 18:3 | ↓ | ↑ |
LPC | LPC(20:4) | 20:4 | ↓ | ↑ |
LPC | LPC(22:6) | 22:6 | ↓ | ↑ |
PC | PC(34:0) | 16:0/18:0 | − | ↑ |
PC | PC(36:0) | 18:0/18:0 | − | ↑ |
PC | PC(36:4)b | 16:0/20:4 | − | ↑ |
PC | PC(38:4)b | 18:0/20:4 | − | ↑ |
PC | PC(38:5) | 18:1/20:4 | − | ↑ |
PC | PC(38:6)a | 18:2/20:4 | ↓ | ↑ |
PC | PC(38:6)b | 16:0/22:6 | − | ↑ |
PC | PC(40:4) | 18:0/22:4 | − | ↑ |
PC | PC(40:5) | 20:1/20:4 | − | ↑ |
PC | PC(40:6)b | 18:0/22:6 | − | ↑ |
PC | PC(40:7) | 18:1/22:6 | − | ↑ |
PC | PC(40:8) | N.D. | ↓ | ↑ |
PC | PC(42:7) | N.D. | − | ↑ |
PC | PC(42:10) | 20:4/22:6 | ↓ | ↑ |
ePE | PE(38:5e)a | N.D. | − | ↑ |
ePE | PE(38:5e)b | N.D. | − | ↑ |
ePE | PE(40:5e) | N.D. | − | ↑ |
PI | PI(36:4) | 16:0/20:4 | − | ↑ |
PI | PI(40:6) | 18:0/22:6 | − | ↑ |
SM | SM(34:1) | N.D. | − | ↑ |
SM | SM(34:2) | N.D. | − | ↑ |
SM | SM(40:2) | N.D. | − | ↑ |
SM | SM(42:2) | N.D. | − | ↑ |
SM | SM(42:4) | N.D. | − | ↑ |
Cer | Cer(42:1) | N.D. | ↓ | − |
TG | TG(54:6)b | 16:0/18:2/20:4 | − | ↑ |
TG | TG(56:5) | 16:0/18:1/22:4 | − | ↑ |
TG | TG(56:6) | 18:1/18:1/20:4 | − | ↑ |
TG | TG(58:6) | 18:1/18:1/22:4 | − | ↑ |
TG | TG(58:7) | N.D. | − | ↑ |
TG | TG(60:8) | N.D. | − | ↑ |
TG | TG(60:9) | 18:1/18:2/24:6, 18:1/20:3/22:5 | − | ↑ |
TG | TG(60:10) | N.D. | − | ↑ |
TG | TG(62:11) | N.D. | − | ↑ |